nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolutegravir—UGT1A1—Losartan—type 2 diabetes mellitus	0.327	1	CbGbCtD
Dolutegravir—POU2F2—Ectoderm Differentiation—ARX—type 2 diabetes mellitus	0.0183	0.0855	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—PHOX2A—type 2 diabetes mellitus	0.0166	0.0775	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—NEUROD1—type 2 diabetes mellitus	0.0107	0.05	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.0087	0.0407	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.00808	0.0379	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.00808	0.0379	CbGpPWpGaD
Dolutegravir—UGT1A1—Codeine and Morphine Metabolism—ABCC2—type 2 diabetes mellitus	0.00777	0.0364	CbGpPWpGaD
Dolutegravir—UGT1A1—Heme degradation—HMOX1—type 2 diabetes mellitus	0.00541	0.0253	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—SPRY2—type 2 diabetes mellitus	0.00526	0.0246	CbGpPWpGaD
Dolutegravir—UGT1A1—Codeine and Morphine Metabolism—CYP3A4—type 2 diabetes mellitus	0.00509	0.0238	CbGpPWpGaD
Dolutegravir—UGT1A1—Irinotecan Pathway—ABCC2—type 2 diabetes mellitus	0.00497	0.0233	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.00425	0.0199	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—PAX6—type 2 diabetes mellitus	0.00424	0.0199	CbGpPWpGaD
Dolutegravir—POU2F2—BCR signaling pathway—CALM1—type 2 diabetes mellitus	0.00418	0.0196	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.00414	0.0194	CbGpPWpGaD
Dolutegravir—POU2F2—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—type 2 diabetes mellitus	0.00405	0.019	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.00371	0.0174	CbGpPWpGaD
Dolutegravir—UGT1A1—Glucuronidation—HK1—type 2 diabetes mellitus	0.00327	0.0153	CbGpPWpGaD
Dolutegravir—UGT1A1—Irinotecan Pathway—CYP3A4—type 2 diabetes mellitus	0.00325	0.0152	CbGpPWpGaD
Dolutegravir—UGT1A1—Constitutive Androstane Receptor Pathway—NCOA6—type 2 diabetes mellitus	0.0032	0.015	CbGpPWpGaD
Dolutegravir—POU2F2—BCR signaling pathway—PIK3R1—type 2 diabetes mellitus	0.00312	0.0146	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.00297	0.0139	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.00294	0.0138	CbGpPWpGaD
Dolutegravir—POU2F2—BCR signaling pathway—RELA—type 2 diabetes mellitus	0.00294	0.0137	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.00277	0.013	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.00277	0.013	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.00274	0.0128	CbGpPWpGaD
Dolutegravir—UGT1A1—Estrogen metabolism—CYP1A2—type 2 diabetes mellitus	0.00273	0.0128	CbGpPWpGaD
Dolutegravir—UGT1A1—Estrogen metabolism—CYP3A4—type 2 diabetes mellitus	0.00266	0.0125	CbGpPWpGaD
Dolutegravir—UGT1A1—Constitutive Androstane Receptor Pathway—ABCC2—type 2 diabetes mellitus	0.00256	0.012	CbGpPWpGaD
Dolutegravir—POU2F2—BCR signaling pathway—NFKB1—type 2 diabetes mellitus	0.00248	0.0116	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.00238	0.0111	CbGpPWpGaD
Dolutegravir—UGT1A1—Porphyrin metabolism—HMOX1—type 2 diabetes mellitus	0.00235	0.011	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.00217	0.0102	CbGpPWpGaD
Dolutegravir—UGT1A1—Estrogen metabolism—GSTM1—type 2 diabetes mellitus	0.00209	0.0098	CbGpPWpGaD
Dolutegravir—POU2F2—Ectoderm Differentiation—CCL2—type 2 diabetes mellitus	0.00196	0.00919	CbGpPWpGaD
Dolutegravir—UGT1A1—Phase II conjugation—MAT1A—type 2 diabetes mellitus	0.00191	0.00895	CbGpPWpGaD
Dolutegravir—UGT1A1—Constitutive Androstane Receptor Pathway—CYP3A4—type 2 diabetes mellitus	0.00168	0.00787	CbGpPWpGaD
Dolutegravir—POU2F2—BCR signaling pathway—AKT1—type 2 diabetes mellitus	0.00143	0.00671	CbGpPWpGaD
Dolutegravir—UGT1A1—Constitutive Androstane Receptor Pathway—PPARGC1A—type 2 diabetes mellitus	0.00142	0.00667	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.00135	0.0063	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A2—type 2 diabetes mellitus	0.00129	0.00603	CbGpPWpGaD
Dolutegravir—UGT1A1—NRF2 pathway—SLC5A4—type 2 diabetes mellitus	0.00128	0.00597	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.00126	0.0059	CbGpPWpGaD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.00114	0.00535	CbGpPWpGaD
Dolutegravir—UGT1A1—Biological oxidations—MAT1A—type 2 diabetes mellitus	0.00112	0.00524	CbGpPWpGaD
Dolutegravir—Nausea—Acarbose—type 2 diabetes mellitus	0.00106	0.00231	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Metformin—type 2 diabetes mellitus	0.00106	0.00231	CcSEcCtD
Dolutegravir—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00106	0.0023	CcSEcCtD
Dolutegravir—Mental disorder—Gliclazide—type 2 diabetes mellitus	0.00105	0.00229	CcSEcCtD
Dolutegravir—Insomnia—Glimepiride—type 2 diabetes mellitus	0.00104	0.00227	CcSEcCtD
Dolutegravir—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.00104	0.00226	CcSEcCtD
Dolutegravir—Renal failure—Irbesartan—type 2 diabetes mellitus	0.00104	0.00226	CcSEcCtD
Dolutegravir—Blood creatinine increased—Ramipril—type 2 diabetes mellitus	0.00104	0.00226	CcSEcCtD
Dolutegravir—Flatulence—Gliclazide—type 2 diabetes mellitus	0.00103	0.00224	CcSEcCtD
Dolutegravir—Nausea—Nateglinide—type 2 diabetes mellitus	0.00102	0.00223	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.00102	0.00222	CcSEcCtD
Dolutegravir—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00102	0.00222	CcSEcCtD
Dolutegravir—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.00102	0.00222	CcSEcCtD
Dolutegravir—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.00102	0.00222	CcSEcCtD
Dolutegravir—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.00101	0.0022	CcSEcCtD
Dolutegravir—Abdominal pain upper—Ramipril—type 2 diabetes mellitus	0.00101	0.0022	CcSEcCtD
Dolutegravir—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.00101	0.0022	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.00101	0.0022	CcSEcCtD
Dolutegravir—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.00101	0.00219	CcSEcCtD
Dolutegravir—Hepatitis—Metformin—type 2 diabetes mellitus	0.00101	0.00219	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Irbesartan—type 2 diabetes mellitus	0.000999	0.00218	CcSEcCtD
Dolutegravir—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000998	0.00217	CcSEcCtD
Dolutegravir—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.000997	0.00217	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000995	0.00217	CcSEcCtD
Dolutegravir—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000994	0.00216	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000992	0.00216	CcSEcCtD
Dolutegravir—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000991	0.00216	CcSEcCtD
Dolutegravir—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.000985	0.00215	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	0.000979	0.00459	CbGpPWpGaD
Dolutegravir—Renal failure—Losartan—type 2 diabetes mellitus	0.000977	0.00213	CcSEcCtD
Dolutegravir—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000976	0.00213	CcSEcCtD
Dolutegravir—UGT1A1—Phase II conjugation—MTR—type 2 diabetes mellitus	0.00097	0.00454	CbGpPWpGaD
Dolutegravir—Mental disorder—Valsartan—type 2 diabetes mellitus	0.000967	0.00211	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—SLC5A2—type 2 diabetes mellitus	0.000967	0.00453	CbGpPWpGaD
Dolutegravir—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000965	0.0021	CcSEcCtD
Dolutegravir—Mental disorder—Orlistat—type 2 diabetes mellitus	0.000956	0.00208	CcSEcCtD
Dolutegravir—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000949	0.00207	CcSEcCtD
Dolutegravir—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.000949	0.00207	CcSEcCtD
Dolutegravir—Flatulence—Valsartan—type 2 diabetes mellitus	0.000947	0.00206	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000942	0.00205	CcSEcCtD
Dolutegravir—Rash—Repaglinide—type 2 diabetes mellitus	0.000941	0.00205	CcSEcCtD
Dolutegravir—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.00094	0.00205	CcSEcCtD
Dolutegravir—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00094	0.00205	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000939	0.00205	CcSEcCtD
Dolutegravir—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000937	0.00204	CcSEcCtD
Dolutegravir—Flatulence—Orlistat—type 2 diabetes mellitus	0.000936	0.00204	CcSEcCtD
Dolutegravir—Headache—Repaglinide—type 2 diabetes mellitus	0.000935	0.00204	CcSEcCtD
Dolutegravir—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000933	0.00203	CcSEcCtD
Dolutegravir—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000932	0.00203	CcSEcCtD
Dolutegravir—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.00093	0.00202	CcSEcCtD
Dolutegravir—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.000917	0.002	CcSEcCtD
Dolutegravir—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000911	0.00198	CcSEcCtD
Dolutegravir—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00091	0.00198	CcSEcCtD
Dolutegravir—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000908	0.00198	CcSEcCtD
Dolutegravir—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000908	0.00198	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000898	0.00195	CcSEcCtD
Dolutegravir—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000896	0.00195	CcSEcCtD
Dolutegravir—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000894	0.00195	CcSEcCtD
Dolutegravir—Hepatitis—Losartan—type 2 diabetes mellitus	0.000893	0.00194	CcSEcCtD
Dolutegravir—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00089	0.00194	CcSEcCtD
Dolutegravir—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000889	0.00194	CcSEcCtD
Dolutegravir—Nausea—Repaglinide—type 2 diabetes mellitus	0.000887	0.00193	CcSEcCtD
Dolutegravir—Asthenia—Glipizide—type 2 diabetes mellitus	0.000886	0.00193	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000884	0.00193	CcSEcCtD
Dolutegravir—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000884	0.00192	CcSEcCtD
Dolutegravir—Pruritus—Glipizide—type 2 diabetes mellitus	0.000874	0.0019	CcSEcCtD
Dolutegravir—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000872	0.0019	CcSEcCtD
Dolutegravir—Vertigo—Valsartan—type 2 diabetes mellitus	0.000863	0.00188	CcSEcCtD
Dolutegravir—Flatulence—Metformin—type 2 diabetes mellitus	0.000862	0.00188	CcSEcCtD
Dolutegravir—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000857	0.00187	CcSEcCtD
Dolutegravir—Vertigo—Orlistat—type 2 diabetes mellitus	0.000853	0.00186	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00085	0.00185	CcSEcCtD
Dolutegravir—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000849	0.00185	CcSEcCtD
Dolutegravir—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000849	0.00185	CcSEcCtD
Dolutegravir—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000846	0.00184	CcSEcCtD
Dolutegravir—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000845	0.00184	CcSEcCtD
Dolutegravir—Renal failure—Ramipril—type 2 diabetes mellitus	0.000838	0.00183	CcSEcCtD
Dolutegravir—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000838	0.00182	CcSEcCtD
Dolutegravir—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000837	0.00182	CcSEcCtD
Dolutegravir—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000829	0.00181	CcSEcCtD
Dolutegravir—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000827	0.0018	CcSEcCtD
Dolutegravir—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000824	0.00179	CcSEcCtD
Dolutegravir—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000822	0.00179	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000821	0.00179	CcSEcCtD
Dolutegravir—Dizziness—Glipizide—type 2 diabetes mellitus	0.000817	0.00178	CcSEcCtD
Dolutegravir—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000815	0.00178	CcSEcCtD
Dolutegravir—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000814	0.00177	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000812	0.00177	CcSEcCtD
Dolutegravir—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00081	0.00176	CcSEcCtD
Dolutegravir—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000806	0.00176	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000803	0.00175	CcSEcCtD
Dolutegravir—POU2F2—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	0.00079	0.0037	CbGpPWpGaD
Dolutegravir—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000789	0.00172	CcSEcCtD
Dolutegravir—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000786	0.00171	CcSEcCtD
Dolutegravir—Vomiting—Glipizide—type 2 diabetes mellitus	0.000785	0.00171	CcSEcCtD
Dolutegravir—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000782	0.0017	CcSEcCtD
Dolutegravir—Rash—Glipizide—type 2 diabetes mellitus	0.000779	0.0017	CcSEcCtD
Dolutegravir—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000778	0.00169	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000777	0.00169	CcSEcCtD
Dolutegravir—Headache—Glipizide—type 2 diabetes mellitus	0.000774	0.00168	CcSEcCtD
Dolutegravir—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000772	0.00168	CcSEcCtD
Dolutegravir—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000769	0.00167	CcSEcCtD
Dolutegravir—UGT1A1—Phase II conjugation—CYP1A2—type 2 diabetes mellitus	0.000767	0.00359	CbGpPWpGaD
Dolutegravir—Flatulence—Losartan—type 2 diabetes mellitus	0.000766	0.00167	CcSEcCtD
Dolutegravir—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000765	0.00167	CcSEcCtD
Dolutegravir—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000762	0.00166	CcSEcCtD
Dolutegravir—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000762	0.00166	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—ABCC2—type 2 diabetes mellitus	0.000761	0.00356	CbGpPWpGaD
Dolutegravir—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00076	0.00165	CcSEcCtD
Dolutegravir—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00076	0.00165	CcSEcCtD
Dolutegravir—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000753	0.00164	CcSEcCtD
Dolutegravir—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000751	0.00164	CcSEcCtD
Dolutegravir—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000746	0.00162	CcSEcCtD
Dolutegravir—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000742	0.00162	CcSEcCtD
Dolutegravir—Headache—Pioglitazone—type 2 diabetes mellitus	0.000741	0.00161	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.00074	0.00161	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000737	0.0016	CcSEcCtD
Dolutegravir—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000736	0.0016	CcSEcCtD
Dolutegravir—Nausea—Glipizide—type 2 diabetes mellitus	0.000734	0.0016	CcSEcCtD
Dolutegravir—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000733	0.0016	CcSEcCtD
Dolutegravir—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00073	0.00159	CcSEcCtD
Dolutegravir—Rash—Glimepiride—type 2 diabetes mellitus	0.000727	0.00158	CcSEcCtD
Dolutegravir—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000726	0.00158	CcSEcCtD
Dolutegravir—Rash—Sitagliptin—type 2 diabetes mellitus	0.000724	0.00158	CcSEcCtD
Dolutegravir—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000724	0.00158	CcSEcCtD
Dolutegravir—Headache—Glimepiride—type 2 diabetes mellitus	0.000722	0.00157	CcSEcCtD
Dolutegravir—Headache—Sitagliptin—type 2 diabetes mellitus	0.00072	0.00157	CcSEcCtD
Dolutegravir—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000711	0.00155	CcSEcCtD
Dolutegravir—Insomnia—Valsartan—type 2 diabetes mellitus	0.000709	0.00154	CcSEcCtD
Dolutegravir—Insomnia—Orlistat—type 2 diabetes mellitus	0.000701	0.00153	CcSEcCtD
Dolutegravir—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.0007	0.00152	CcSEcCtD
Dolutegravir—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.0007	0.00152	CcSEcCtD
Dolutegravir—Vertigo—Losartan—type 2 diabetes mellitus	0.000698	0.00152	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000698	0.00152	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000698	0.00152	CcSEcCtD
Dolutegravir—Skin disorder—Metformin—type 2 diabetes mellitus	0.000694	0.00151	CcSEcCtD
Dolutegravir—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000691	0.00151	CcSEcCtD
Dolutegravir—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000688	0.0015	CcSEcCtD
Dolutegravir—Nausea—Glimepiride—type 2 diabetes mellitus	0.000685	0.00149	CcSEcCtD
Dolutegravir—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000682	0.00149	CcSEcCtD
Dolutegravir—Asthenia—Glyburide—type 2 diabetes mellitus	0.000682	0.00148	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000677	0.00147	CcSEcCtD
Dolutegravir—Fatigue—Valsartan—type 2 diabetes mellitus	0.000676	0.00147	CcSEcCtD
Dolutegravir—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000675	0.00147	CcSEcCtD
Dolutegravir—Pruritus—Glyburide—type 2 diabetes mellitus	0.000672	0.00146	CcSEcCtD
Dolutegravir—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000671	0.00146	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000669	0.00146	CcSEcCtD
Dolutegravir—Fatigue—Orlistat—type 2 diabetes mellitus	0.000668	0.00145	CcSEcCtD
Dolutegravir—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000661	0.00144	CcSEcCtD
Dolutegravir—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000661	0.00144	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—SLC2A2—type 2 diabetes mellitus	0.00066	0.00309	CbGpPWpGaD
Dolutegravir—Rash—Bromocriptine—type 2 diabetes mellitus	0.000656	0.00143	CcSEcCtD
Dolutegravir—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000655	0.00143	CcSEcCtD
Dolutegravir—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000655	0.00143	CcSEcCtD
Dolutegravir—Headache—Bromocriptine—type 2 diabetes mellitus	0.000651	0.00142	CcSEcCtD
Dolutegravir—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00065	0.00142	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000641	0.0014	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000634	0.00138	CcSEcCtD
Dolutegravir—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000629	0.00137	CcSEcCtD
Dolutegravir—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000622	0.00135	CcSEcCtD
Dolutegravir—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00062	0.00135	CcSEcCtD
Dolutegravir—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000618	0.00134	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000617	0.00134	CcSEcCtD
Dolutegravir—Fatigue—Metformin—type 2 diabetes mellitus	0.000616	0.00134	CcSEcCtD
Dolutegravir—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000613	0.00133	CcSEcCtD
Dolutegravir—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000612	0.00133	CcSEcCtD
Dolutegravir—Vomiting—Glyburide—type 2 diabetes mellitus	0.000604	0.00132	CcSEcCtD
Dolutegravir—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000604	0.00131	CcSEcCtD
Dolutegravir—Rash—Glyburide—type 2 diabetes mellitus	0.000599	0.0013	CcSEcCtD
Dolutegravir—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000599	0.0013	CcSEcCtD
Dolutegravir—Vertigo—Ramipril—type 2 diabetes mellitus	0.000599	0.0013	CcSEcCtD
Dolutegravir—Headache—Glyburide—type 2 diabetes mellitus	0.000595	0.0013	CcSEcCtD
Dolutegravir—UGT1A1—Phase II conjugation—GSTM1—type 2 diabetes mellitus	0.000588	0.00275	CbGpPWpGaD
Dolutegravir—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000584	0.00127	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000584	0.00127	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000582	0.00127	CcSEcCtD
Dolutegravir—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000581	0.00127	CcSEcCtD
Dolutegravir—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000578	0.00126	CcSEcCtD
Dolutegravir—Insomnia—Losartan—type 2 diabetes mellitus	0.000574	0.00125	CcSEcCtD
Dolutegravir—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000571	0.00124	CcSEcCtD
Dolutegravir—UGT1A1—Biological oxidations—MTR—type 2 diabetes mellitus	0.000568	0.00266	CbGpPWpGaD
Dolutegravir—Nausea—Glyburide—type 2 diabetes mellitus	0.000565	0.00123	CcSEcCtD
Dolutegravir—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000565	0.00123	CcSEcCtD
Dolutegravir—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000564	0.00123	CcSEcCtD
Dolutegravir—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000563	0.00123	CcSEcCtD
Dolutegravir—Asthenia—Valsartan—type 2 diabetes mellitus	0.000563	0.00123	CcSEcCtD
Dolutegravir—Asthenia—Orlistat—type 2 diabetes mellitus	0.000556	0.00121	CcSEcCtD
Dolutegravir—Pruritus—Valsartan—type 2 diabetes mellitus	0.000555	0.00121	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000551	0.0012	CcSEcCtD
Dolutegravir—UGT1A1—Biological oxidations—CYP11A1—type 2 diabetes mellitus	0.00055	0.00257	CbGpPWpGaD
Dolutegravir—Pruritus—Orlistat—type 2 diabetes mellitus	0.000548	0.00119	CcSEcCtD
Dolutegravir—Fatigue—Losartan—type 2 diabetes mellitus	0.000547	0.00119	CcSEcCtD
Dolutegravir—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000543	0.00118	CcSEcCtD
Dolutegravir—UGT1A1—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	0.000542	0.00254	CbGpPWpGaD
Dolutegravir—Rash—Gliclazide—type 2 diabetes mellitus	0.000538	0.00117	CcSEcCtD
Dolutegravir—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000538	0.00117	CcSEcCtD
Dolutegravir—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000537	0.00117	CcSEcCtD
Dolutegravir—Headache—Gliclazide—type 2 diabetes mellitus	0.000535	0.00116	CcSEcCtD
Dolutegravir—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000533	0.00116	CcSEcCtD
Dolutegravir—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000533	0.00116	CcSEcCtD
Dolutegravir—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00053	0.00115	CcSEcCtD
Dolutegravir—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000528	0.00115	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000519	0.00113	CcSEcCtD
Dolutegravir—Dizziness—Valsartan—type 2 diabetes mellitus	0.000519	0.00113	CcSEcCtD
Dolutegravir—Dizziness—Orlistat—type 2 diabetes mellitus	0.000512	0.00112	CcSEcCtD
Dolutegravir—Asthenia—Metformin—type 2 diabetes mellitus	0.000512	0.00112	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—SLC2A1—type 2 diabetes mellitus	0.000511	0.0024	CbGpPWpGaD
Dolutegravir—Nausea—Gliclazide—type 2 diabetes mellitus	0.000507	0.0011	CcSEcCtD
Dolutegravir—Pruritus—Metformin—type 2 diabetes mellitus	0.000505	0.0011	CcSEcCtD
Dolutegravir—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000501	0.00109	CcSEcCtD
Dolutegravir—Vomiting—Valsartan—type 2 diabetes mellitus	0.000499	0.00109	CcSEcCtD
Dolutegravir—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000496	0.00108	CcSEcCtD
Dolutegravir—Rash—Valsartan—type 2 diabetes mellitus	0.000494	0.00108	CcSEcCtD
Dolutegravir—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000494	0.00108	CcSEcCtD
Dolutegravir—Vomiting—Orlistat—type 2 diabetes mellitus	0.000493	0.00107	CcSEcCtD
Dolutegravir—Insomnia—Ramipril—type 2 diabetes mellitus	0.000492	0.00107	CcSEcCtD
Dolutegravir—Headache—Valsartan—type 2 diabetes mellitus	0.000491	0.00107	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—SLC2A4—type 2 diabetes mellitus	0.00049	0.0023	CbGpPWpGaD
Dolutegravir—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000489	0.00106	CcSEcCtD
Dolutegravir—Rash—Orlistat—type 2 diabetes mellitus	0.000489	0.00106	CcSEcCtD
Dolutegravir—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000488	0.00106	CcSEcCtD
Dolutegravir—Headache—Orlistat—type 2 diabetes mellitus	0.000485	0.00106	CcSEcCtD
Dolutegravir—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000484	0.00105	CcSEcCtD
Dolutegravir—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000477	0.00104	CcSEcCtD
Dolutegravir—Dizziness—Metformin—type 2 diabetes mellitus	0.000472	0.00103	CcSEcCtD
Dolutegravir—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000469	0.00102	CcSEcCtD
Dolutegravir—Fatigue—Ramipril—type 2 diabetes mellitus	0.000469	0.00102	CcSEcCtD
Dolutegravir—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000467	0.00102	CcSEcCtD
Dolutegravir—Nausea—Valsartan—type 2 diabetes mellitus	0.000466	0.00101	CcSEcCtD
Dolutegravir—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000461	0.001	CcSEcCtD
Dolutegravir—Nausea—Orlistat—type 2 diabetes mellitus	0.00046	0.001	CcSEcCtD
Dolutegravir—Asthenia—Losartan—type 2 diabetes mellitus	0.000455	0.000991	CcSEcCtD
Dolutegravir—Vomiting—Metformin—type 2 diabetes mellitus	0.000454	0.000989	CcSEcCtD
Dolutegravir—UGT1A1—Biological oxidations—CYP2E1—type 2 diabetes mellitus	0.000454	0.00212	CbGpPWpGaD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—SRC—type 2 diabetes mellitus	0.00045	0.00211	CbGpPWpGaD
Dolutegravir—Rash—Metformin—type 2 diabetes mellitus	0.00045	0.00098	CcSEcCtD
Dolutegravir—Dermatitis—Metformin—type 2 diabetes mellitus	0.00045	0.000979	CcSEcCtD
Dolutegravir—Pruritus—Losartan—type 2 diabetes mellitus	0.000449	0.000977	CcSEcCtD
Dolutegravir—UGT1A1—Biological oxidations—CYP1A2—type 2 diabetes mellitus	0.000449	0.0021	CbGpPWpGaD
Dolutegravir—UGT1A1—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	0.000447	0.0021	CbGpPWpGaD
Dolutegravir—Headache—Metformin—type 2 diabetes mellitus	0.000447	0.000974	CcSEcCtD
Dolutegravir—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000446	0.00097	CcSEcCtD
Dolutegravir—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000445	0.000968	CcSEcCtD
Dolutegravir—UGT1A1—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	0.000442	0.00207	CbGpPWpGaD
Dolutegravir—UGT1A1—Biological oxidations—CYP3A4—type 2 diabetes mellitus	0.000438	0.00205	CbGpPWpGaD
Dolutegravir—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000434	0.000945	CcSEcCtD
Dolutegravir—UGT1A1—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	0.000431	0.00202	CbGpPWpGaD
Dolutegravir—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00043	0.000936	CcSEcCtD
Dolutegravir—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000428	0.000933	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—TGFBR2—type 2 diabetes mellitus	0.000427	0.002	CbGpPWpGaD
Dolutegravir—Rash—Irbesartan—type 2 diabetes mellitus	0.000425	0.000925	CcSEcCtD
Dolutegravir—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000425	0.000924	CcSEcCtD
Dolutegravir—Nausea—Metformin—type 2 diabetes mellitus	0.000424	0.000924	CcSEcCtD
Dolutegravir—Headache—Irbesartan—type 2 diabetes mellitus	0.000422	0.000919	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—HMOX1—type 2 diabetes mellitus	0.000421	0.00197	CbGpPWpGaD
Dolutegravir—Dizziness—Losartan—type 2 diabetes mellitus	0.000419	0.000913	CcSEcCtD
Dolutegravir—Vomiting—Losartan—type 2 diabetes mellitus	0.000403	0.000878	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—type 2 diabetes mellitus	0.000403	0.00188	CbGpPWpGaD
Dolutegravir—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000401	0.000872	CcSEcCtD
Dolutegravir—Nausea—Irbesartan—type 2 diabetes mellitus	0.0004	0.000872	CcSEcCtD
Dolutegravir—Rash—Losartan—type 2 diabetes mellitus	0.0004	0.000871	CcSEcCtD
Dolutegravir—Dermatitis—Losartan—type 2 diabetes mellitus	0.0004	0.00087	CcSEcCtD
Dolutegravir—Headache—Losartan—type 2 diabetes mellitus	0.000397	0.000865	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—type 2 diabetes mellitus	0.000395	0.00185	CbGpPWpGaD
Dolutegravir—UGT1A1—NRF2 pathway—GSTM1—type 2 diabetes mellitus	0.000392	0.00184	CbGpPWpGaD
Dolutegravir—Asthenia—Ramipril—type 2 diabetes mellitus	0.00039	0.00085	CcSEcCtD
Dolutegravir—Pruritus—Ramipril—type 2 diabetes mellitus	0.000385	0.000838	CcSEcCtD
Dolutegravir—UGT1A1—NRF2 pathway—AGER—type 2 diabetes mellitus	0.000378	0.00177	CbGpPWpGaD
Dolutegravir—Nausea—Losartan—type 2 diabetes mellitus	0.000377	0.00082	CcSEcCtD
Dolutegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—type 2 diabetes mellitus	0.000376	0.00176	CbGpPWpGaD
Dolutegravir—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000372	0.00081	CcSEcCtD
Dolutegravir—Dizziness—Ramipril—type 2 diabetes mellitus	0.00036	0.000783	CcSEcCtD
Dolutegravir—Vomiting—Ramipril—type 2 diabetes mellitus	0.000346	0.000753	CcSEcCtD
Dolutegravir—UGT1A1—Biological oxidations—GSTM1—type 2 diabetes mellitus	0.000344	0.00161	CbGpPWpGaD
Dolutegravir—Rash—Ramipril—type 2 diabetes mellitus	0.000343	0.000747	CcSEcCtD
Dolutegravir—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000343	0.000746	CcSEcCtD
Dolutegravir—Headache—Ramipril—type 2 diabetes mellitus	0.000341	0.000742	CcSEcCtD
Dolutegravir—UGT1A1—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	0.000339	0.00159	CbGpPWpGaD
Dolutegravir—Nausea—Ramipril—type 2 diabetes mellitus	0.000323	0.000703	CcSEcCtD
Dolutegravir—UGT1A1—Metabolism—BHMT—type 2 diabetes mellitus	0.000262	0.00123	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PTGDS—type 2 diabetes mellitus	0.000229	0.00107	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—AANAT—type 2 diabetes mellitus	0.000229	0.00107	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CDO1—type 2 diabetes mellitus	0.000217	0.00102	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GPD2—type 2 diabetes mellitus	0.000217	0.00102	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—AK1—type 2 diabetes mellitus	0.000207	0.000971	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000191	0.000896	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—MAT1A—type 2 diabetes mellitus	0.000191	0.000896	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ND1—type 2 diabetes mellitus	0.000185	0.000865	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000185	0.000865	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—HBA2—type 2 diabetes mellitus	0.000185	0.000865	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ENPP1—type 2 diabetes mellitus	0.000185	0.000865	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—G6PC—type 2 diabetes mellitus	0.000185	0.000865	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GCGR—type 2 diabetes mellitus	0.000179	0.000838	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYTB—type 2 diabetes mellitus	0.000169	0.000791	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—OXCT1—type 2 diabetes mellitus	0.000169	0.000791	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000165	0.000771	CbGpPWpGaD
Dolutegravir—UGT1A1—NRF2 pathway—TGFB1—type 2 diabetes mellitus	0.00016	0.000748	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ACACA—type 2 diabetes mellitus	0.000157	0.000736	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000157	0.000736	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—STAR—type 2 diabetes mellitus	0.000157	0.000736	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CBS—type 2 diabetes mellitus	0.000151	0.000705	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ABCC8—type 2 diabetes mellitus	0.000151	0.000705	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—COX2—type 2 diabetes mellitus	0.000145	0.000679	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000145	0.000679	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—NCOA6—type 2 diabetes mellitus	0.000142	0.000667	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—UCP3—type 2 diabetes mellitus	0.00014	0.000656	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—HSD11B1—type 2 diabetes mellitus	0.00014	0.000656	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—UCP2—type 2 diabetes mellitus	0.00014	0.000656	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PCK1—type 2 diabetes mellitus	0.000132	0.000616	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—HK1—type 2 diabetes mellitus	0.000123	0.000577	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000119	0.000558	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—LPA—type 2 diabetes mellitus	0.000119	0.000558	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000119	0.000558	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GCKR—type 2 diabetes mellitus	0.000119	0.000558	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ALDOB—type 2 diabetes mellitus	0.000114	0.000534	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GLP1R—type 2 diabetes mellitus	0.000106	0.000497	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SLC2A2—type 2 diabetes mellitus	9.91e-05	0.000464	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CPT1A—type 2 diabetes mellitus	9.71e-05	0.000454	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—MTR—type 2 diabetes mellitus	9.71e-05	0.000454	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—NAMPT—type 2 diabetes mellitus	9.52e-05	0.000446	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—HBA1—type 2 diabetes mellitus	9.46e-05	0.000443	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—LIPC—type 2 diabetes mellitus	9.46e-05	0.000443	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GCK—type 2 diabetes mellitus	9.46e-05	0.000443	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYP11A1—type 2 diabetes mellitus	9.4e-05	0.00044	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SLC9A1—type 2 diabetes mellitus	9.23e-05	0.000432	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CETP—type 2 diabetes mellitus	9.13e-05	0.000427	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PSMD6—type 2 diabetes mellitus	8.48e-05	0.000397	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SREBF1—type 2 diabetes mellitus	8.48e-05	0.000397	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SNAP25—type 2 diabetes mellitus	8.48e-05	0.000397	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CTGF—type 2 diabetes mellitus	8.33e-05	0.00039	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—HMGCR—type 2 diabetes mellitus	8.25e-05	0.000386	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ADRA2A—type 2 diabetes mellitus	8.08e-05	0.000378	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYP2E1—type 2 diabetes mellitus	7.76e-05	0.000363	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYP1A2—type 2 diabetes mellitus	7.67e-05	0.000359	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SLC2A1—type 2 diabetes mellitus	7.67e-05	0.000359	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CYP3A4—type 2 diabetes mellitus	7.48e-05	0.00035	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—SLC2A4—type 2 diabetes mellitus	7.36e-05	0.000344	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GCG—type 2 diabetes mellitus	7.36e-05	0.000344	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GNB3—type 2 diabetes mellitus	6.34e-05	0.000297	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.34e-05	0.000297	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—HMOX1—type 2 diabetes mellitus	6.31e-05	0.000296	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CAT—type 2 diabetes mellitus	6.23e-05	0.000292	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—APOB—type 2 diabetes mellitus	6.04e-05	0.000283	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GSTM1—type 2 diabetes mellitus	5.88e-05	0.000275	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—LPL—type 2 diabetes mellitus	5.77e-05	0.00027	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ADCY5—type 2 diabetes mellitus	5.65e-05	0.000265	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—GPX1—type 2 diabetes mellitus	5.63e-05	0.000264	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CD36—type 2 diabetes mellitus	5.48e-05	0.000257	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.42e-05	0.000254	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—MTHFR—type 2 diabetes mellitus	5.2e-05	0.000243	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PPARA—type 2 diabetes mellitus	5.1e-05	0.000239	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—AGT—type 2 diabetes mellitus	4.94e-05	0.000231	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—CALM1—type 2 diabetes mellitus	4.86e-05	0.000227	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—APOE—type 2 diabetes mellitus	4.84e-05	0.000227	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—APOA1—type 2 diabetes mellitus	4.78e-05	0.000224	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PPARG—type 2 diabetes mellitus	4.21e-05	0.000197	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—INS—type 2 diabetes mellitus	4.13e-05	0.000194	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—ALB—type 2 diabetes mellitus	3.79e-05	0.000177	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—NOS3—type 2 diabetes mellitus	3.62e-05	0.00017	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.62e-05	0.00017	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—PTGS2—type 2 diabetes mellitus	3.32e-05	0.000155	CbGpPWpGaD
Dolutegravir—UGT1A1—Metabolism—AKT1—type 2 diabetes mellitus	1.67e-05	7.8e-05	CbGpPWpGaD
